Coexpression of MYC and BCL-2 predicts prognosis in primary gastrointestinal diffuse large B-cell lymphoma

doi:10.3748/wjg.v21.i8.2433

Advanced Search

BPG is committed to discovery and dissemination of knowledge

Home / Archive / Volume 21, Issue 8

This Article

Academic Content and Language Evaluation of This Article

Citation of this article

Corresponding Author of This Article

Research Domain of This Article

Article-Type of This Article

Open-Access Policy of This Article

Times Cited Counts in Google of This Article

Number of Hits and Downloads for This Article

Total Article Views (6908)

All Articles published online

The chart showing PDF series, WORD series, HTML series, Figures (1-5) series, Tables (1-6) series.

Item

Count

PDF

406

WORD

222

HTML

3408

Figures (1-5)

229

Tables (1-6)

187

Sum=4452

Publishing Process of This Article

The chart showing Browse series, Download series.

Item

Count

Browse

1050

Download

1406

Sum=2456

Feb 28, 2015 (publication date) through Nov 18, 2024

Times Cited of This Article

Times Cited (14)

Journal Information of This Article

Publication Name

World Journal of Gastroenterology

ISSN

1007-9327

Publisher of This Article

Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA

Clinical Trials Study

World J Gastroenterol. Feb 28, 2015; 21(8): 2433-2442
Published online Feb 28, 2015. doi: 10.3748/wjg.v21.i8.2433

Full Size Figure Download Figure

Figure 4 Survival analysis of primary gastrointestinal diffuse large B-cell lymphoma. The effects of age (A), Lugano stage (B), IPI score (C), the expression of BCL-2 protein (D), and treatment (E) on progression-free survival (PFS); And the effects of Lugano stage (F), IPI score (G) and BCL-2 protein expression (H) on overall survival (OS). ST: Surgery; CT: Chemotherapy; RT: Radiotherapy; IPI: International prognostic index.

Citation: Xia B, Zhang L, Guo SQ, Li XW, Qu FL, Zhao HF, Zhang LY, Sun BC, You J, Zhang YZ. Coexpression of MYC and BCL-2 predicts prognosis in primary gastrointestinal diffuse large B-cell lymphoma. World J Gastroenterol 2015; 21(8): 2433-2442
URL: https://www.wjgnet.com/1007-9327/full/v21/i8/2433.htm
DOI: https://dx.doi.org/10.3748/wjg.v21.i8.2433